The medical technology company Bibb Instruments has during the fourth quarter received new orders for Endodrill GI from its U.S. distribution partner Taewoong Medical USA to a total value of approximately SEK 300,000. This is stated in a press release."Additional orders from our partner in the USA are proof that the launch underway is proceeding according to plan and that the Bibb team's tour of U.S. hospitals in November paid off. The order value so far during the fourth quarter exceeds sales in the third quarter by just over 170 percent," says Fredrik Lindblad, CEO of Bibb Instruments..Taewoong is focusing on establishing regular use at a number of larger reference hospitals, which will form the basis for a broader national launch in 2026. In parallel, discussions are underway with potential distribution partners in Europe, with the aim of also introducing Endodrill GI to the European market in 2026, the company writes.